The Cigna Group (NYSE:CI) Shares Sold by Systematic Alpha Investments LLC

Systematic Alpha Investments LLC lessened its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 44.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,581 shares of the health services provider's stock after selling 1,240 shares during the quarter. Systematic Alpha Investments LLC's holdings in The Cigna Group were worth $437,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of CI. TCTC Holdings LLC acquired a new stake in shares of The Cigna Group in the 4th quarter valued at approximately $25,000. Collier Financial acquired a new position in shares of The Cigna Group during the 4th quarter worth $32,000. ORG Wealth Partners LLC purchased a new stake in The Cigna Group during the fourth quarter worth about $34,000. Compagnie Lombard Odier SCmA acquired a new position in The Cigna Group during the fourth quarter worth about $37,000. Finally, Heck Capital Advisors LLC purchased a new position in The Cigna Group in the fourth quarter valued at about $53,000. 86.99% of the stock is owned by institutional investors and hedge funds.

The Cigna Group Trading Down 2.3 %

NYSE:CI traded down $7.51 during mid-day trading on Monday, reaching $314.90. The company's stock had a trading volume of 2,918,116 shares, compared to its average volume of 1,674,473. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The stock has a market cap of $86.18 billion, a P/E ratio of 25.73, a P/E/G ratio of 0.98 and a beta of 0.51. The company's fifty day simple moving average is $308.72 and its two-hundred day simple moving average is $312.39. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83.

Remove Ads

The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter last year, the firm earned $6.79 earnings per share. On average, equities analysts predict that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th were issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.92%. This is an increase from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date was Wednesday, March 5th. The Cigna Group's dividend payout ratio is presently 49.35%.

Insider Buying and Selling

In other news, Director Elder Granger sold 2,376 shares of the stock in a transaction on Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the completion of the sale, the director now owns 5,471 shares of the company's stock, valued at $1,697,924.85. This represents a 30.28 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Nicole S. Jones sold 4,904 shares of The Cigna Group stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the transaction, the insider now owns 29,421 shares in the company, valued at $9,065,198.52. The trade was a 14.29 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 43,751 shares of company stock valued at $13,603,991. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts have weighed in on CI shares. Truist Financial lowered their target price on The Cigna Group from $390.00 to $375.00 and set a "buy" rating on the stock in a report on Tuesday, February 4th. StockNews.com upgraded shares of The Cigna Group from a "buy" rating to a "strong-buy" rating in a report on Saturday, March 29th. Stephens reduced their price target on shares of The Cigna Group from $410.00 to $380.00 and set an "overweight" rating on the stock in a report on Friday, January 31st. Raymond James reissued a "strong-buy" rating and set a $360.00 price objective (down from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Finally, Royal Bank of Canada set a $355.00 target price on The Cigna Group in a research note on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $373.25.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.